[Selective surfactant treatment for neonatal respiratory distress syndrome].
The modification of respiratory support, applied in infants breathing by nasal CPAP devices is discussed. On the ground of data obtained in several clinical trials and theirs own experiences, the authors suggest intubation in infants the increasing oxygen requirements, when the value of FiO(2) is above 0.45 and brief instillation of surfactant. After positive pressure ventilation, lasting several minutes, the infant is extubated and the breathing is continued by the nasal CPAP as a noninvasive respiratory support.
Pawlik
Dorota
D
Klinika Neonatologii Uniwersytetu Jagiellońskiego Collegium Medicum, 31-501 Kraków.
Lauterbach
Ryszard
R
D045422:Continuous Positive Airway Pressure; D006801:Humans; D007231:Infant, Newborn; D010100:Oxygen / Q000008:administration & dosage; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*; D013501:Surface-Active Agents / Q000008:administration & dosage*
D013501:Surface-Active Agents; D010100:Oxygen